Company page

Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc. is a public company traded under the ticker GLUE in the American market. The company has a market capitalization of approximately $1.92 billion. Monte Rosa focuses on developing innovative therapies to address unmet medical needs.

GLUE:NASDAQUpdated September 11, 2026
Monte Rosa Therapeutics, Inc. logo
Ticker
GLUE:NASDAQ
Asset type
Stock
Market cap
$1.20B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD